Vision-Sciences announced that the detailed findings of a twelve-month evaluation of its EndoSheath technology in the critical care setting were presented in a scientific poster at the 67th National Congress of the Società Italiana di Anestesia Analgesia Rianimazione e Terapia Intensiva, or SIAARTI. During the twelve-month study period, investigators used Vision-Sciences' bronchoscope with EndoSheath technology to perform bronchoscopic procedures (n=53) including bronchial aspirate, bronchoalveolar lavage, and percutaneous tracheostomy. The device was cultured three times for each procedure: before the application of the EndoSheath; after the procedure and removal of the EndoSheath; and, after enzymatic cleaning, drying and disinfection with 70% ethanol. A sterile pledget was wiped on the entire surface of the insertion tube and a second one on the entire surface of the control head. Both were placed in sterile specimen containers for culture. The operator deliberately contaminated two results for control purposes by touching several areas and other devices in the ICU. As expected, these two results tested positive for bacterial contamination with Staphylococcus or Sphingomonas paucimobilis. The remaining 51 procedures tested negative for bacterial contamination.